Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is conducted to assess the relative bioavailability of MTX administered
subcutaneously via a prefilled pen (50mg/mL) compared with MTX administered via IM injection
(25mg/mL).